Lumbar discectomy has been proven to be an effective therapy for decompression of patients with herniated disc. So the question was asked, can the nucleus pulposus be regenerated, or as TSB would say remodeled? By identifying the viscoelastic properties of the nucleus pulposus the objective was to create a scaffold capable of integration without mechanical compromise. Many scientists believe that the swelling properties of blending PVA and PVP might allow spine surgeons to replace the NP endoscopically vis-a-vis a posterior approach.
Over the past ten years, companies have raised a tremendous amount of capital, and have also burned through an incredible amount. Some of it for research, some of it for marketing and of course some of it for its own personal use. Yet, the question, must be asked, is there a viable market of this material in spine? Some of the companies that surfaced believed if they could prove this materials efficacy, a windfall would occur. But somewhere along the beaten path it seems that the market for this material, as originally intended, is not as large in spine as it may be in other segments of medicine. So the question must be asked of our readers, is there hope for this material? And, how large of a market exists? And, do some of these companies stand the chance to execute and capitalize on their strategic objectives? Or, are their expectations greater than the reality that awaits them? TSB wants to know what our readers think?